Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03168438 |
|---|---|
| Brief Title: | Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma |
| First Submitted : | May 24, 2017 |
| First Submitted that Met QC Criteria : | May 24, 2017 |
| First Posted : | May 30, 2017 |
| Results First Submitted : | November 9, 2021 |
| Results First Submitted that Met QC Criteria : | November 9, 2021 |
| Results First Posted : | January 11, 2022 |
| Last Update Submitted that Met QC Criteria : | November 9, 2021 |
| Last Update Posted : | January 11, 2022 |